Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account

Table of contents

DetailsRelated

Exhibit 11(a) - Joint Meeting of Arthritis Advisory Committee Tanenzumab Advisory Materials Briefing Document (Mar. 24-25 2021)

FDA-2026-P-6249-0018Supporting & Related Material
Document

Details

The document's own metadata, straight from the source system.

Title
Exhibit 11(a) - Joint Meeting of Arthritis Advisory Committee Tanenzumab Advisory Materials Briefing Document (Mar. 24-25 2021)
Posted
Jun 3, 2026
Agency
Food and Drug Administration (FDA)
Topics
View on regulations.gov ↗